Literature DB >> 18782302

The management of renal matrix calculi: a single-centre experience over 5 years.

Hemendra N Shah1, Shabbir Kharodawala, Hiren S Sodha, Amit A Khandkar, Sunil S Hegde, Manish B Bansal.   

Abstract

OBJECTIVE: To define incidence of renal matrix calculi in patients undergoing percutaneous nephrolithotomy (PCNL), and describe its clinical, laboratory and radiological features; we also studied the efficacy of PCNL in managing this rare entity. PATIENTS AND METHODS: We retrospectively reviewed the records of 1368 PCNLs performed from April 2003 to March 2008, and identified 17 patients (mean age 44.3 years; 11 women and six men) having matrix calculi. The patients' clinical, laboratory and radiological features were studied, and the perioperative outcome and follow-up data analysed.
RESULTS: Flank pain was commonest mode of presentation (15) followed by recurrent urinary tract infection (five). Pyuria was present in 14 patients and urine culture showed significant growth in 10. A plain X-ray showed a small radio-opaque calculus (10 renal units) and faint laminated calcification (four). Intravenous urography showed a filling defect and non-visualized system in nine and five patients, respectively. Non-contrast computed tomography and magnetic resonance urography diagnosed calculi in two and one patient, respectively, on haemodialysis. PCNL was abandoned initially in four patients due to pyonephrosis. The mean hospital stay was 3.4 days and decrease in haemoglobin was 0.89 g/dL. One patient developed sepsis. Of 11 stones analysed, two were composed entirely of proteins and the remaining nine had crystalline components. At a mean follow-up of 12.6 months, no patients had recurrence of stone.
CONCLUSIONS: Matrix calculi occurred in 1.24% of patients undergoing PCNL. Although considered radiolucent, plain X-ray showed a small radio-opaque calculi or faint laminated calcifications in 10 of 17 patients. PCNL rendered patients stone-free with minimum morbidity.

Entities:  

Mesh:

Year:  2008        PMID: 18782302     DOI: 10.1111/j.1464-410X.2008.08065.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Matrix stone in ureter and bladder simultaneously.

Authors:  Ying Yang; Nan Chen; Wei Xu
Journal:  Jpn J Radiol       Date:  2012-08-18       Impact factor: 2.374

2.  Proteomic analysis of a matrix stone: a case report.

Authors:  Benjamin K Canales; Lorraine Anderson; LeeAnn Higgins; Chris Frethem; Alice Ressler; Il Won Kim; Manoj Monga
Journal:  Urol Res       Date:  2009-12

3.  Antibiotics therapy was effective in preventing bilateral staghorn renal matrix stones.

Authors:  Sotaro Miwa; Hidekazu Yamamoto; Toshiaki Sugata
Journal:  Urol Res       Date:  2010-01-28

4.  Bilateral kidney matrix stones: a rare case.

Authors:  Mounir Lahyani; Yassine Rhannam; Amine Slaoui; Alae Touzani; Tarik Karmouni; Khalid Elkhader; Abdellatif Koutani; Ahmed Ibn Attya Andaloussi
Journal:  Pan Afr Med J       Date:  2016-10-20

5.  Matrix Stone Occupying an Entire Renal Collecting System: A Case Report and Video of Diagnostic Ureterorenoscopy.

Authors:  Jonathan Cobley; Yih Chyn Phan; Wasim Mahmalji
Journal:  Case Rep Urol       Date:  2018-04-23

6.  Radiolucent Pure Matrix Stones on Computed Tomography Scan, Arising in Patient with Type I Diabetes and Chronic Kidney Disease: A Case Report.

Authors:  Young-Woong Song; Ju-Heon Kim; Kitae Bang; Jong Ho Shin; Kyeong Min Kim; Jinuk Jeong
Journal:  Korean J Fam Med       Date:  2022-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.